{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:23:46Z","timestamp":1789694626362,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province","award":["2022E10022"],"award-info":[{"award-number":["2022E10022"]}]},{"name":"the Zhejiang Province Natural Science Foundation of China","award":["LY20H200004"],"award-info":[{"award-number":["LY20H200004"]}]},{"name":"the Major Projects of Wenzhou Science and Technology Bureau","award":["ZY2019011"],"award-info":[{"award-number":["ZY2019011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-03950-4","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T10:55:16Z","timestamp":1744628116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gallium nitrate inhibits multidrug-resistant Acinetobacter baumannii isolated from bloodstream infection by disrupting multiple iron-dependent metabolic processes"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhuocheng","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaihang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changrui","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishuai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tieli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiliang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"3950_CR1","doi-asserted-by":"publisher","first-page":"106252","DOI":"10.1016\/j.micpath.2023.106252","volume":"182","author":"Y Lin","year":"2023","unstructured":"Lin Y, Zhao D, Huang N, Liu S, Zheng J, Cao J, et al. Clinical impact of the type VI secretion system on clinical characteristics, virulence and prognosis of acinetobacter baumannii during bloodstream infection. Microb Pathog. 2023;182:106252.","journal-title":"Microb Pathog"},{"key":"3950_CR2","doi-asserted-by":"publisher","first-page":"1141490","DOI":"10.3389\/fcimb.2023.1141490","volume":"13","author":"C Sun","year":"2023","unstructured":"Sun C, Yu Y, Hua X. Resistance mechanisms of tigecycline in acinetobacter baumannii. Front Cell Infect Microbiol. 2023;13:1141490.","journal-title":"Front Cell Infect Microbiol"},{"issue":"10","key":"3950_CR3","doi-asserted-by":"publisher","first-page":"ofaa378","DOI":"10.1093\/ofid\/ofaa378","volume":"7","author":"HJ Son","year":"2020","unstructured":"Son HJ, Cho EB, Bae M, Lee SC, Sung H, Kim MN, et al. Clinical and microbiological analysis of risk factors for mortality in patients with carbapenem-resistant acinetobacter baumannii bacteremia. Open Forum Infect Dis. 2020;7(10):ofaa378.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"3950_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13756-020-00876-6","volume":"10","author":"K Yu","year":"2021","unstructured":"Yu K, Zeng W, Xu Y, Liao W, Xu W, Zhou T, et al. Bloodstream infections caused by ST2 acinetobacter baumannii: risk factors, antibiotic regimens, and virulence over 6 years period in China. Antimicrob Resist Infect Control. 2021;10(1):16.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"Suppl 1","key":"3950_CR5","first-page":"S15","volume":"22","author":"XDRCWG Chinese","year":"2016","unstructured":"Chinese XDRCWG, Guan X, He L, Hu B, Hu J, Huang X, et al. Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative Bacilli: a Chinese consensus statement. Clin Microbiol Infect. 2016;22(Suppl 1):S15\u201325.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"3950_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12929-023-00914-6","volume":"30","author":"J Jo","year":"2023","unstructured":"Jo J, Kwon KT, Ko KS. Multiple heteroresistance to tigecycline and colistin in acinetobacter baumannii isolates and its implications for combined antibiotic treatment. J Biomed Sci. 2023;30(1):37.","journal-title":"J Biomed Sci"},{"key":"3950_CR7","doi-asserted-by":"crossref","unstructured":"Artuso I, Poddar H, Evans BA, Visca P. Genomics of acinetobacter baumannii iron uptake. Microb Genom. 2023;9(8).","DOI":"10.1099\/mgen.0.001080"},{"issue":"10","key":"3950_CR8","doi-asserted-by":"publisher","first-page":"e0022322","DOI":"10.1128\/iai.00223-22","volume":"90","author":"S Cook-Libin","year":"2022","unstructured":"Cook-Libin S, Sykes EME, Kornelsen V, Kumar A. Iron acquisition mechanisms and their role in the virulence of acinetobacter baumannii. Infect Immun. 2022;90(10):e0022322.","journal-title":"Infect Immun"},{"key":"3950_CR9","doi-asserted-by":"publisher","first-page":"108066","DOI":"10.1016\/j.abb.2019.108066","volume":"672","author":"BJ Giardina","year":"2019","unstructured":"Giardina BJ, Shahzad S, Huang W, Wilks A. Heme uptake and utilization by hypervirulent acinetobacter baumannii LAC-4 is dependent on a canonical heme oxygenase (abHemO). Arch Biochem Biophys. 2019;672:108066.","journal-title":"Arch Biochem Biophys"},{"issue":"10","key":"3950_CR10","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1021\/acsinfecdis.9b00271","volume":"5","author":"Y Guo","year":"2019","unstructured":"Guo Y, Li W, Li H, Xia W. Identification and characterization of a metalloprotein involved in gallium internalization in pseudomonas aeruginosa. ACS Infect Dis. 2019;5(10):1693\u20137.","journal-title":"ACS Infect Dis"},{"key":"3950_CR11","doi-asserted-by":"crossref","unstructured":"Vinuesa V, Cruces R, Nonnoi F, McConnell MJ. Inhibition of LpxC increases the activity of iron chelators and gallium nitrate in multidrug-resistant acinetobacter baumannii. Antibiot (Basel). 2021;10(5).","DOI":"10.3390\/antibiotics10050609"},{"key":"3950_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fcimb.2018.00316","volume":"8","author":"S Hijazi","year":"2018","unstructured":"Hijazi S, Visaggio D, Pirolo M, Frangipani E, Bernstein L, Visca P. Antimicrobial activity of gallium compounds on ESKAPE pathogens. Front Cell Infect Microbiol. 2018;8:316.","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"3950_CR13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.coph.2013.07.001","volume":"13","author":"AB Kelson","year":"2013","unstructured":"Kelson AB, Carnevali M, Truong-Le V. Gallium-based anti-infectives: targeting microbial iron-uptake mechanisms. Curr Opin Pharmacol. 2013;13(5):707\u201316.","journal-title":"Curr Opin Pharmacol"},{"issue":"24","key":"3950_CR14","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.1039\/C9SC01480B","volume":"10","author":"Y Wang","year":"2019","unstructured":"Wang Y, Han B, Xie Y, Wang H, Wang R, Xia W, et al. Combination of gallium(iii) with acetate for combating antibiotic resistant pseudomonas aeruginosa. Chem Sci. 2019;10(24):6099\u2013106.","journal-title":"Chem Sci"},{"issue":"11","key":"3950_CR15","doi-asserted-by":"publisher","first-page":"5961","DOI":"10.1128\/AAC.01519-12","volume":"56","author":"LC Antunes","year":"2012","unstructured":"Antunes LC, Imperi F, Minandri F, Visca P. In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant acinetobacter baumannii. Antimicrob Agents Chemother. 2012;56(11):5961\u201370.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"3950_CR16","doi-asserted-by":"publisher","first-page":"7657","DOI":"10.1128\/AAC.01472-15","volume":"59","author":"BA Arivett","year":"2015","unstructured":"Arivett BA, Fiester SE, Ohneck EJ, Penwell WF, Kaufman CM, Relich RF, et al. Antimicrobial activity of gallium protoporphyrin IX against acinetobacter baumannii strains displaying different antibiotic resistance phenotypes. Antimicrob Agents Chemother. 2015;59(12):7657\u201365.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3950_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1039\/D0TB00174K","volume":"9","author":"L Li","year":"2021","unstructured":"Li L, Chang H, Yong N, Li M, Hou Y, Rao W. Superior antibacterial activity of gallium based liquid metals due to Ga(3+) induced intracellular ROS generation. J Mater Chem B. 2021;9(1):85\u201393.","journal-title":"J Mater Chem B"},{"key":"3950_CR18","doi-asserted-by":"crossref","unstructured":"Gall T, Balla G, Balla J, Heme. Heme oxygenase, and endoplasmic reticulum stress-a new insight into the pathophysiology of vascular diseases. Int J Mol Sci. 2019;20(15).","DOI":"10.3390\/ijms20153675"},{"issue":"4","key":"3950_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1039\/C9NP00046A","volume":"37","author":"WY Song","year":"2020","unstructured":"Song WY, Kim HJ. Current biochemical understanding regarding the metabolism of acinetobactin, the major siderophore of the human pathogen acinetobacter baumannii, and outlook for discovery of novel anti-infectious agents based thereon. Nat Prod Rep. 2020;37(4):477\u201387.","journal-title":"Nat Prod Rep"},{"issue":"3","key":"3950_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.resmic.2010.10.010","volume":"162","author":"LC Antunes","year":"2011","unstructured":"Antunes LC, Imperi F, Towner KJ, Visca P. Genome-assisted identification of putative iron-utilization genes in acinetobacter baumannii and their distribution among a genotypically diverse collection of clinical isolates. Res Microbiol. 2011;162(3):279\u201384.","journal-title":"Res Microbiol"},{"key":"3950_CR21","doi-asserted-by":"crossref","unstructured":"Paternoga H, Crowe-McAuliffe C, Bock LV, Koller TO, Morici M, Beckert B et al. Structural conservation of antibiotic interaction with ribosomes. Nat Struct Mol Biol. 2023;30(9):1380-92.","DOI":"10.1038\/s41594-023-01047-y"},{"issue":"6","key":"3950_CR22","doi-asserted-by":"publisher","first-page":"973","DOI":"10.4014\/jmb.1903.03008","volume":"29","author":"T Song","year":"2019","unstructured":"Song T, Zhao X, Shao Y, Guo M, Li C, Zhang W. Gallium(III) nitrate inhibits pathogenic vibrio splendidus vs by interfering with the iron uptake pathway. J Microbiol Biotechnol. 2019;29(6):973\u201383.","journal-title":"J Microbiol Biotechnol"},{"issue":"8","key":"3950_CR23","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1021\/acsinfecdis.1c00280","volume":"7","author":"W Xia","year":"2021","unstructured":"Xia W, Li N, Shan H, Lin Y, Yin F, Yu X, et al. Gallium porphyrin and gallium nitrate reduce the high vancomycin tolerance of MRSA biofilms by promoting extracellular DNA-dependent biofilm dispersion. ACS Infect Dis. 2021;7(8):2565\u201382.","journal-title":"ACS Infect Dis"},{"key":"3950_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fcimb.2017.00012","volume":"7","author":"S Hijazi","year":"2017","unstructured":"Hijazi S, Visca P, Frangipani E, Gallium-Protoporphyrin IX. Inhibits pseudomonas aeruginosa growth by targeting cytochromes. Front Cell Infect Microbiol. 2017;7:12.","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"3950_CR25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"3950_CR26","doi-asserted-by":"publisher","first-page":"115569","DOI":"10.1016\/j.diagmicrobio.2021.115569","volume":"102","author":"L Rossato","year":"2021","unstructured":"Rossato L, Arantes JP, Ribeiro SM, Simionatto S. Antibacterial activity of gallium nitrate against polymyxin-resistant Klebsiella pneumoniae strains. Diagn Microbiol Infect Dis. 2021;102(2):115569.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"3950_CR27","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/jac\/dkx038","volume":"72","author":"YF Zhou","year":"2017","unstructured":"Zhou YF, Tao MT, Feng Y, Yang RS, Liao XP, Liu YH, et al. Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1. J Antimicrob Chemother. 2017;72(6):1723\u201330.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"3950_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S1040-8428(01)00225-6","volume":"42","author":"P Collery","year":"2002","unstructured":"Collery P, Keppler B, Madoulet C, Desoize B. Gallium in cancer treatment. Crit Rev Oncol Hematol. 2002;42(3):283\u201396.","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03950-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-03950-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03950-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T10:55:18Z","timestamp":1744628118000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-03950-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3950"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-03950-4","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"27 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Ethics Committee in clinical research of the First Affiliated Hospital of Wenzhou Medical University (No. KY2022-R117), which waived the requirement for informed consent given the observational nature of this study, mainly focused on bacteria and involved no interventions with patients. Patient information was anonymized and de-identified during the entire process of data recording. All experiments were performed in compliance with the relevant laws and institutional guidelines in accordance with the ethical standards of the Declaration of Helsinki. Animal studies were approved by the Ethics Committee for Experimental Animals of the First Affiliated Hospital of Wenzhou Medical University (No. SYXK (Zhejiang) 2021-0017) and conducted in accordance with Wenzhou Laboratory Animal Welfare and ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"216"}}